HUM
21
3
KMX
50
4
PVH
37
3
MAT
54
4
PRGO
50
4
JPM
66
6
MTCH
68
8
AMAT
55
7
APH
50
8
RL
58
3
IBM
72
2
EIX
64
2
NWSA
33
-4
FLS
52
8
KLAC
70
8
JNJ
78
-11
QRVO
71
3
CLX
55
3
GILD
68
4
COST
58
2
HUM
21
3
KMX
50
4
PVH
37
3
MAT
54
4
PRGO
50
4
JPM
66
6
MTCH
68
8
AMAT
55
7
APH
50
8
RL
58
3
IBM
72
2
EIX
64
2
NWSA
33
-4
FLS
52
8
KLAC
70
8
JNJ
78
-11
QRVO
71
3
CLX
55
3
GILD
68
4
COST
58
2
Financhill
Back

State Street SPDR S&P Pharmaceuticals ETF Stock Predictions

This Company Solves Remote Work with Virtual HQs

*DISCLOSURE: This is a paid advertisement for Immersed Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks immersed.com
Buy
59

XPH
State Street SPDR S&P Pharmaceuticals ETF

Last Price:
$57.26
Seasonality Move:
0.05%

7 Day Trial

ALL ACCESS PASS

$ 7

Most Pre-IPO Big Tech Shifts Look Like This at the Start

*DISCLOSURE: This is a paid advertisement for Immersed Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks immersed.com

State Street SPDR S&P Pharmaceuticals ETF Stock Forecast

  • Over the next 52 weeks, State Street SPDR S&P Pharmaceuticals ETF has on average historically risen by 7.8% based on the past 19 years of stock performance.
  • State Street SPDR S&P Pharmaceuticals ETF has risen higher in 12 of those 19 years over the subsequent 52-week period, corresponding to a historical accuracy of 63.16%
  • Is State Street SPDR S&P Pharmaceuticals ETF Stock Undervalued?
    The current State Street SPDR S&P Pharmaceuticals ETF [XPH] share price is $57.27. The Score for XPH is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
  • XPH is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will State Street SPDR S&P Pharmaceuticals ETF Stock Go Up Next Year?

  • Over the next 52 weeks, State Street SPDR S&P Pharmaceuticals ETF has on average historically risen by 7.8% based on the past 19 years of stock performance.

State Street SPDR S&P Pharmaceuticals ETF Stock Rating

Buy
59
State Street SPDR S&P Pharmaceuticals ETF (XPH) is a Buy

Is State Street SPDR S&P Pharmaceuticals ETF overpriced?

  • State Street SPDR S&P Pharmaceuticals ETF has risen higher in 12 of those 19 years over the subsequent 52-week period, corresponding to a historical accuracy of 63.16%

State Street SPDR S&P Pharmaceuticals ETF Stock Price History

Is XPH stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and XPH is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NYSEARCA
Country:
Industry:
Sector:
Type:
etf
Website:

52-Week Data

52-Week High:
58.00
52-Week Low:
35.22

Prediction Charts

Market Cap:
0
Price in USD:
57.27
Volume:
69.4K
Beta:
0.79

Technical Analysis

SMA50:
55.93
SMA100:
52.36
SMA200:
47.47
52-Wk Change:
26.48%

Stock Predictions

  • Is State Street SPDR S&P Pharmaceuticals ETF stock public?
    Yes, State Street SPDR S&P Pharmaceuticals ETF is a publicly traded company.
  • What is the State Street SPDR S&P Pharmaceuticals ETF stock quote today?
    The State Street SPDR S&P Pharmaceuticals ETF stock price is 57.27 USD today.
  • How to buy State Street SPDR S&P Pharmaceuticals ETF stock online?
    You can buy State Street SPDR S&P Pharmaceuticals ETF shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jan-20 54.93 56.48 56.59 54.80
Jan-21 56.65 57.02 57.03 56.21
Jan-22 57.22 57.51 58.00 57.09
Jan-23 57.37 56.28 57.49 56.16
Jan-26 56.00 56.36 56.37 55.77
Jan-27 56.16 56.75 56.82 56.16
Jan-28 56.70 55.39 56.70 55.39
Jan-29 55.62 55.83 55.99 55.39
Jan-30 55.49 55.43 55.89 54.80
Feb-2 55.45 57.04 57.05 55.45
Feb-3 56.93 57.07 57.64 56.37
Feb-4 57.40 56.81 57.41 56.30
Feb-5 56.34 55.67 57.84 55.51
Feb-6 56.31 57.27 57.29 56.31

State Street SPDR S&P Pharmaceuticals ETF Earnings

Data Unavailable

State Street SPDR S&P Pharmaceuticals ETF Forecast Revenue Growth

Data Unavailable

* State Street SPDR S&P Pharmaceuticals ETF stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.